Minisymposia in Cardiovascular Medicine


Speakers:

Prof John-Bjarne Hansen, Department of Clinical Medicine, University of Tromsø, Norway

Title: ‘Interrelations between arterial and venous thromboembolic diseases’ 

John-Bjarne Hansen is is a clinical specialist and professor in hematology. He leads the K.G.Jebsen – Thrombosis Research and Expertise Center (TREC) which focus on inherited and non-inherited risk factors of venous thrombosis and to extend the understanding of the pathogenesis of venous thrombosis. He is the principal investigator of the Tromsø study, a North Norwegian population based cohort study that generated many recognized publications about epidemiology in venous thromboembolism.

John-Bjarne is assistant editor of Journal of Thrombosis and Haemostasis.

 

Dr David Trégouët, INSERM, Institute for Cardiometabolism and Nutrition, Pierre & Marie Curie Medical School, Paris, France

Title: ‘Novel insights into the (epi-)genetic epidemiology of arterial and venous thrombosis through the prism of high-throughput technologies’

David-Alexandre Trégouët is a world leader in the development of statistical tools and research strategies for the analysis of high-dimensional biological data generated by high-throughput technologies and their application to cardiovascular disease with a focus on venous thromboembolism. He belongs to the statistical core group of several international projects including MORGAM, EURAGEDIC, CardioGenics and CARDomics.

David is a member of the editorial board of the Arteriosclerosis Thrombosis and Vascular Biology, Human Genetics, Journal of Molecular Medicine and BMC Medical Genetics journals.

Host: Jacob Odeberg, Professor at KTH Royal Institute of Tehcnology and SciLifeLab faculty

 

In connection to the symposia MD Maria Bruzelius will defend her PhD-thesis November 13.
Time and venue: Lecture Hall, L8:00, CMM, Karolinska University Hospital, Solna

Title: Exploration of novel mechanisms and biomarkers for venous thromboembolism
– a genetics and proteomics study

Opponent: Professor John-Bjarne Hansen, University of Tromsø, Norway, Department of Clinical Medicine

Examination Board:

Professor Eva Hellström-Lindberg, Karolinska Institutet, Department of Medicine Huddinge

Docent Masood Kamali-Moghaddam, Uppsala University, Department of Immunology, Genetics and Pathology

Docent Pelle Lindqvist, Karolinska Institutet, Department of Clinical Science,
Intervention and Technology

Principal Supervisor:

Professor Jacob Odeberg, Royal Institute of Technology (KTH), School of Biotechnology, Science for Life Laboratory Stockholm, Division of Proteomics

Karolinska Institutet. Department of Medicine Solna, Cardiovascular Medicine Unit

Co-supervisors:

Professor Anders Hamsten, Karolinska Institutet. Department of Medicine Solna, Atherosclerosis Research Unit

Ph.D. Rona J. Strawbridge, Karolinska Institutet. Department of Medicine Solna, Cardiovascular Medicine Unit